Cancer clinical trials in the region Pays de la Loire

374 currently recruiting clinical trials
Region Pays de la Loire

Phase 2 Sarcoma and GIST #NCT06022159
Soft tissue sarcoma Localized None Systemic Treatment-Naive
Chemotherapy Radiotherapy
10 recruiting sites
Institut Claudius Regaud
Phase 2 Breast cancer #NCT06680596 #2024-515349-41-00
HER2 Low HR Positive Metastatic None
Antibody Drug Conjugates (ADC) Hormone therapy
34 recruiting sites
UNICANCER
Phase 2 Colon cancer Rectal cancer #NCT04659382
Metastatic MSS/pMMR None Systemic Treatment-Naive
MSI/dMMR
6 recruiting sites
Fédération Francophone de Cancérologie Digestive
Phase 2 Prostate cancer #NCT06866938 #2024-512043-22-00
Adenocarcinoma Metastatic Castration-resistant PSMA PET Positive Chemotherapy Hormone therapy
Systemic Treatment-Naive
4 recruiting sites
Hospices Civils de Lyon
Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT04678362 #2024-516182-37-01
Invasive bladder cancer Upper excretory tract cancer Urethral cancer Urothelial carcinoma Other Locally Advanced Metastatic None Chemotherapy
Immunotherapy Targeted therapy
10 recruiting sites
Centre François Baclesse
Phase 2 Breast cancer #NCT05955170 #2022-500743-20-00
HER2 Positive Metastatic 1 Chemotherapy Targeted therapy Chemotherapy Targeted therapy
9 recruiting sites
Institut Curie
Phase 2 Sarcoma and GIST #NCT04698785
Bone sarcoma Locally Advanced None 1 Systemic Treatment-Naive Chemotherapy
Targeted therapy
8 recruiting sites
Centre Léon Bérard
Phase 2 Sarcoma and GIST #NCT05182164 #2023-509496-16-00
Bone sarcoma Soft tissue sarcoma Osteosarcoma Ewing tumor Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive Immunotherapy
6 recruiting sites
Institut Bergonié
Phase 2 Lung cancer Colon cancer Rectal cancer Endometrial cancer Head and neck cancer Sarcoma and GIST #NCT07192068 #2025-522169-31-00
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic HER2 1 2 3 or more
Systemic Treatment-Naive
4 recruiting sites
UNICANCER
Phase 2 Pancreas cancer Sarcoma and GIST #NCT05732831 #2022-502645-99-00
Bone sarcoma Soft tissue sarcoma Adenocarcinoma Locally Advanced Metastatic MTAP 1 2 3 or more
Systemic Treatment-Naive
4 recruiting sites
Tango Therapeutics